BioSpace News Archive

Business

Olon S.p.A. Expands Microbial GMP Capabilities at Its Manufacturing Site in Capua

Olon S.p.A. celebrates the start of the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.

July 24, 2019
·
2 min read
Pharm Country

Celgene and the Multiple Sclerosis Association of America Bring MS MindShift Initiative and “Brain Bulb” Hot Air Balloon to Festival to Raise Awareness of Multiple Sclerosis and Brain Health

Celgene Corporation (NASDAQ: CELG) and the Multiple Sclerosis Association of America (MSAA) are bringing the MS MindShift: A New View of MS initiative to the 37th Annual QuickChek New Jersey Festival of Ballooning in Readington, NJ, on July 26-28, where the MS MindShift “Brain Bulb” hot air balloon will fly to raise awareness of multiple sclerosis (MS) and brain health.

July 24, 2019
·
5 min read
Business

Arrowhead Pharmaceuticals to Webcast Fiscal 2019 Third Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on August 5, 2019, at 4:30 p.m. EDT to discuss its financial results for the fiscal 2019 third quarter ended June 30, 2019.

July 24, 2019
·
2 min read
Business

Pennsylvania Biotechnology Center Announces the Launch of Hatch BioFund Management, LLC, a New Investment Arm for Early-Stage Life Sciences Companies

One of the nation’s most successful life sciences incubators forms internal investment program to provide seed and early-stage funding for its companies

July 24, 2019
·
4 min read
FDA

Exogenesis Corporation Announces the Filing of a 510(k) Pre-Marketing Notification Application with the US Food and Drug Administration for Exogenesis Hernia Mesh

Exogenesis Hernia Mesh is the First Soft Tissue Repair Device with Nano-Modified Surface

July 24, 2019
·
3 min read
Drug Development

DelMar Pharmaceuticals Enrolls First Patient in the Recently-Approved Adjuvant Setting Arm of Phase 2 Study of VAL-083 for the Treatment of MGMT-Unmethylated Glioblastoma Multiforme

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) (“DelMar” or the “Company”), today announces that the first patient has been treated in the adjuvant (pre-temozolomide maintenance) trial arm of VAL-083’s Phase 2 study in MGMT-unmethylated glioblastoma multiforme (GBM) being conducted at the University of Texas MD Anderson Cancer Center (MDACC)

July 24, 2019
·
6 min read
Business

Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2019

As of June 30, 2019, Odonate had $206.9 million in cash, compared to $139.1 million as of December 31, 2018.

July 24, 2019
·
10 min read
Business

Dassault Systèmes and the FDA Extend Collaboration to Inform Cardiovascular Device Review Process and Accelerate Access to New Treatments

Dassault Systèmes announced the five-year extension of its collaboration with the U.S. Food and Drug Administration.

July 24, 2019
·
4 min read
Top 5 Vendors in the Urethral Dilator Market from 2019 to 2023 | Technavio

The incidence of urethral stricture disease, in which the urethral opening becomes narrow due to genetic disorders, scars, or infections such as STD, is increasing significantly.

July 24, 2019
·
4 min read
Deals

United Therapeutics Corporation To Report Second Quarter 2019 Financial Results Before The Market Opens On Wednesday, July 31, 2019

United Therapeutics Corporation announced that it will report its second quarter 2019 financial results before the market opens on Wednesday, July 31, 2019.

July 24, 2019
·
1 min read